Century Therapeutics, Inc.
IPSCCIK 0001850119 · Biological Products, (No Diagnostic Substances) · Nasdaq
Revenue (TTM)
$111.58M
+1,556.8% YoY
Q1 May 2026
Net Income (TTM)
−$12.05M
+92.4% YoY
Q1 May 2026
EPS Diluted (TTM)
−$0.00
+91.3% YoY
Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
-18.2%
Q1 May 2026
Net Margin
-10.8%
Q1 May 2026
Free Cash Flow (TTM)
−$125.94M
Q1 May 2026
Cash
$51.05M
Q1 May 2026
Total Debt
$3.74M
Q1 May 2026
Shares Outstanding
180.35M sh
Q1 May 2026